Erector Spinae Plane Block vs Local Infiltration Following Fusion Surgery
NCT06199999
Bone Diseases, Confusion
Iowa City, Iowa, United States
View Trial DetailsNCT Number: NCT02492724
Patients are candidates for single-level Artificial Disc Replacement between C3 and C7 who suffer from cervical symptomatic degenerative disc disease. A maximum of 200 cases will be enrolled into the study. An 18-month recruitment period is planned with a 4-year postoperative follow-up period for each subject. Thus, it is anticipated that the study will require a minimum of 5.5 years. Patients will be assessed preoperatively, intraoperatively, prior to discharge and again at 6 weeks, 6 months, 1 year, 2 years and 4 years postoperatively from the date of surgery.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Regional Hospital Liberec, Liberec, Czechia
The activ C Disc Prosthesis pursues the goal of restoring the disc function, the geometry and motion of the cervical disc. Its concept is based on a ball and socket joint, anchored between adjacent vertebral bodies. The modular prosthesis comprises the following elements: an inferior CoCr plate component anchored in the endplate of the caudal vertebral body. The UHMWPE inlay is securely fixed in this inferior component. The second element is the superior CoCr component, which is anchored in the end plate of the cranial vertebral body. It forms a ball joint with the inlay of the inferior plate component.
The activ C product range enables reconstruction of various disc heights as well as adaptation to the end plate sizes. Secure primary anchorage of the prosthesis to the vertebral bodies is achieved by convexly shaped superior end pla tes and fixation means (spikes and grooves on the superior end plate, a small keel on the inferior end plate), whereas secondary stability is facilitated by an osseointegrative Plasmapore® coating.
The objective of the study is to collect outcome information on the Activ® C Disc Prosthesis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 years
The primary endpoint of the study will be changes in the clinical outcome measured by the Neck Disability Index (NDI) as published by Vernon et. al.
Time frame: 4 years
Time frame: 4 years
Time frame: 4 years
Time frame: 4 years
Time frame: 4 years
Time frame: 4 years
Aesculap AG
Industry
Activ C Disc Prosthesis European Multi-Center Clinical Investigation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06199999
Bone Diseases, Confusion
Iowa City, Iowa, United States
View Trial DetailsNCT04984629
Back Pain, Bone Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT04416321
Bone Diseases, Degenerative Disc Disease
Lancaster, Pennsylvania, United States
View Trial DetailsNCT00948532
Back Pain, Bone Diseases
La Jolla, California, United States
View Trial Details